Biochemical premotor biomarkers for Parkinson's disease

被引：28
|
作者：
Mollenhauer, Brit [1 ,2 ]
Zhang, Jing [3 ]
机构：
[1] Paracelsus Elena Klin, D-34128 Kassel, Germany
[2] Univ Gottingen, Kassel, Germany
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
来源：
MOVEMENT DISORDERS | 2012年 / 27卷 / 05期
关键词：
biomarkers; genomics; metabolomics; Parkinson's disease; premotor; proteomics; HUMAN CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; GENE-EXPRESSION; URIC-ACID; ALZHEIMER; PROTEIN; URATE; DJ-1; CSF; PROTEOMICS;
D O I：
10.1002/mds.24956
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathologic processes or of pharmacologic responses to a therapeutic intervention. We reviewed the current status of target protein biomarkers (eg, total/oligomeric a-synuclein and DJ-1) in cerebrospinal fluid, as well as on unbiased processes that can be used to discover novel biomarkers. We have also provide ddetails about strategies toward potential populations/models and technologies, including the need for standardized sampling techniques, to pursue the identification of new biochemical markers in the premotor stage of Parkinson's disease in the future. (C) 2012 Movement Disorder Society
引用
收藏
页码：644 / 650
页数：7
相关论文
共 50 条
  • [21] The premotor phase of Parkinson's disease
    Tolosa, E.
    Compta, Y.
    Gaig, C.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S2 - S7
  • [22] Premotor diagnosis of Parkinson's disease
    Morales-Briceno, Hugo
    Cervantes-Arriaga, Amin
    Rodriguez-Violante, Mayela
    GACETA MEDICA DE MEXICO, 2011, 147 (01): : 22 - 32
  • [23] Biomarkers in Parkinson's disease: a funder's perspective
    Frasier, Mark
    Chowdhury, Sohini
    Eberling, Jamie
    Sherer, Todd
    BIOMARKERS IN MEDICINE, 2010, 4 (05) : 723 - 729
  • [24] Recent Advances in Biomarkers for Parkinson's Disease
    He, Runcheng
    Yan, Xinxiang
    Guo, Jifeng
    Xu, Qian
    Tang, Beisha
    Sun, Qiying
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [25] Update on CSF Biomarkers in Parkinson's Disease
    Kwon, Eun Hae
    Tennagels, Sabrina
    Gold, Ralf
    Gerwert, Klaus
    Beyer, Leon
    Toenges, Lars
    BIOMOLECULES, 2022, 12 (02)
  • [26] The role of biomarkers and imaging in Parkinson's disease
    Algarni, Musleh A.
    Stoessl, A. Jon
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (02) : 187 - 203
  • [27] Biomarkers for Parkinson's Disease: How Good Are They?
    Li, Tianbai
    Le, Weidong
    NEUROSCIENCE BULLETIN, 2020, 36 (02) : 183 - 194
  • [28] Parkinson's disease - the continuing search for biomarkers
    Breen, David P.
    Michell, Andrew W.
    Barker, Roger A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) : 393 - 401
  • [29] Parkinson's disease biomarkers based on α-synuclein
    Fayyad, Muneera
    Salim, Safa
    Majbour, Nour
    Erskine, Daniel
    Stoops, Erik
    Mollenhauer, Brit
    El-Agnaf, Omar M. A.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 (05) : 626 - 636
  • [30] Biomarkers for Parkinson's Disease
    Sherer, Todd B.
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (79)
12345